Fate therapeutics announces presentation of ft522 preclinical data for autoimmune diseases in late-breaking abstract at asgct annual meeting

Off-the-shelf, cd19-targeted car nk cell product candidate drives rapid and deep depletion of sle donor cd19+ b cells

FATE Ratings Summary

FATE Quant Ranking